Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response

por Pazdera, Ladislav, Cohen, Joshua M, Ning, Xiaoping, Campos, Verena Ramirez, Yang, Ronghua, Pozo-Rosich, Patricia
Publicado 2021

Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

por McAllister, Peter, Cohen, Joshua M., Campos, Verena Ramirez, Ning, Xiaoping, Janka, Lindsay, Barash, Steve
Publicado 2022

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlle...

por Spierings, Egilius L. H., Kärppä, Mikko, Ning, Xiaoping, Cohen, Joshua M., Campos, Verena Ramirez, Yang, Ronghua, Reuter, Uwe
Publicado 2021

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and pro...

por Mackenzie, Kimberly D., Ortega, Mario, Kessler, Yoel, Campos, Verena Ramirez, Krasenbaum, Lynda J., Carr, Karen, Ning, Xiaoping, Stratton, Jennifer
Publicado 2022

Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 m...

por Ashina, Messoud, Cohen, Joshua M., Galic, Maja, Campos, Verena Ramirez, Barash, Steve, Ning, Xiaoping, Kessler, Yoel, Janka, Lindsay, Diener, Hans-Christoph
Publicado 2021

Immunogenicity of biologic therapies for migraine: a review of current evidence

por Cohen, Joshua M., Ning, Xiaoping, Kessler, Yoel, Rasamoelisolo, Michele, Campos, Verena Ramirez, Seminerio, Michael J., Krasenbaum, Lynda J., Shen, Honglue, Stratton, Jennifer
Publicado 2021

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study

por MaassenVanDenBrink, Antoinette, Terwindt, Gisela M., Cohen, Joshua M., Barash, Steve, Campos, Verena Ramirez, Galic, Maja, Ning, Xiaoping, Kärppä, Mikko
Publicado 2021

Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

por Diener, Hans Christoph, McAllister, Peter, Jürgens, Tim P, Kessler, Yoel, Ning, Xiaoping, Cohen, Joshua M, Campos, Verena Ramirez, Barash, Steve, Silberstein, Stephen D
Publicado 2022

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-control...

por Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Publicado 2021

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, pla...

por Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Publicado 2022